Obeticholic Acid NEW
| Price | $41 | $48 | $101 |
| Package | 5mg | 10mg | 50mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Obeticholic Acid | CAS No.: 459789-99-2 |
| Purity: 99.97% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Obeticholic Acid |
| Description | Obeticholic Acid (6-ECDCA, INT-747) is a high-affinity, semisynthetic, bile acid-derived FXR agonist with an EC50 of 99 nM and is able to upregulate IκB-α, KLF-2, and KLF-4 expression. Obeticholic Acid (6-ECDCA, INT-747) also shows potential for treating hepatic steatosis, inflammation, and fibrosis while increasing insulin sensitivity. |
| In vitro | METHODS: SCC cells were treated with increasing concentrations of obeticholic acid (6-ECDCA, INT-747) (0-100 μM), hepatocytes and HSCs were seeded at the same density and treated with obeticholic acid (6-ECDCA, INT-747) (0.1, 1 and 10 μM), and finally MTT assay was performed. RESULTS Obeticholic acid (6-ECDCA, INT-747) reduced cell viability by more than 20% at a concentration of 10 μM. [4] |
| In vivo | METHODS: Thioacetamide (TAA)-intoxicated and bile duct ligation (BDL) rats were used as models. Two oral doses of 30 mg/kg obeticholic acid (INT-747) were administered within 24 hours to evaluate in vivo hemodynamics. The effects of short-term obeticholic acid (INT-747) treatment on intrahepatic hemodynamic dysfunction and signaling pathways in different rat models of cirrhotic portal hypertension (PHT) were investigated. RESULTS FXR expression was decreased in both cirrhotic models. Obeticholic acid (INT-747) administration in TAA and BDL reactivated FXR downstream signaling pathways and reduced portal pressure by reducing total IHVR without causing harmful systemic hypotension. Obeticholic acid (INT-747) improved endothelial vasodilation but not hyperresponsiveness in perfused TAA and BDL cirrhotics. [1] METHODS: Animals were fed a low-salt (control) or high-salt diet and treated with obeticholic acid (6-ECDCA, INT-747) (10, 30 mg/kg/day, oral, 6 weeks). Liver lysates were compared for c-JNK1 and 2 expression by Western blot. RESULTS INT-747 reduced hepatic JNK-1 and JNK-2 expression; proinflammatory proteins may be upregulated by a high-salt diet, thereby interfering with normal insulin signaling. [3] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 45 mg/mL (106.98 mM) Ethanol : 78 mg/mL (185.4 mM) |
| Keywords | Autophagy | orally | NR1H4 | active | farnesoid | INT 747 | FXR | Obeticholic Acid | receptor | Inhibitor | inhibit | INT747 |
| Inhibitors Related | Hydroxychloroquine | Guanidine hydrochloride |
| Related Compound Libraries | Bioactive Compound Library | EMA Approved Drug Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $10.00/1KG |
VIP6Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-12-04 | |
| $0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-11-15 | |
| $10.70/1kg |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-21 | |
| $7.00/25KG |
VIP5Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-09-07 | |
| $1.00/1KG |
Weijer International Trade (Hebei) Co., Ltd
|
2023-03-15 | ||
| $200.00/1kg |
Hebei Mingeng Biotechnology Co., Ltd
|
2022-11-20 | ||
| $0.00/25Kg/Bag |
VIP4Y
|
Sinoway Industrial co., ltd.
|
2022-08-11 | |
| $9.00/1g |
Qiuxian Baitai New Material Co., LTD
|
2021-11-25 | ||
| $10.00/1Kg/Bag |
Hebei Zhanyao Biotechnology Co. Ltd
|
2021-11-08 | ||
| $0.00/25KG |
Hangzhou Huarong Pharm Co., Ltd.
|
2021-09-14 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY